Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.22166 | 77 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.10828 | 76 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.09265 | 76 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.25105 | 76 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.98548 | 75 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.17602 | 78 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.0476 | 66 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.30204 | 78 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.41859 | 78 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.62498 | 79 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.11153 | 76 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.74188 | 80 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.08338 | 76 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.66102 | 80 |